Follow on Google News News By Tag Industry News News By Location Country(s) Industry News
Follow on Google News | Putting worker safety at the forefront of the HPAPI Industry -By: SMi Conferences The HPAPI global market has developed rapidly in the past year and is expected to continue to expand into the future, with over a quarter of drugs in development worldwide being classified as highly potent. As a result, there is a growing demand for both pharmaceutical and contracted manufacturers to adapt to the evolving HPAPI landscape. The event will explore current market trends, challenges of correctly assessing hazard, the use of innovative containment solutions to minimise risk and advanced manufacturing processes. PROGRAMME HIGHLIGHTS: • Interactive debate on the importance of control matrices and algorithms to ensure confidence in containment • Mastering the fundamentals of ADC development with Regeneron • Analysing the principals of containment designs with AstraZeneca • Using case studies by Gedeon Richter to optimise quality risk management • Practical elements in rolling out HPAPI projects • OH/containment strategy and NPI at AbbVie Download the event brochure to view the full two-day agenda https://www.smi- High profile speakers include: Conference Chair: Justin Mason-Home, Director, HPAPI Project Services Limited Featured Speakers: • Dr Olindo Lazzaro, Director, Global EHS Technical Operations, AbbVie • Dr Thomas Adam, Head of Global Quality Assurance Chemical APIs, Bayer • Mr Peter Marshall, Associate Engineering Director, AstraZeneca • Dr Thomas Nittoli, Director, Regeneron • Mr Nigel Saunders, SME Containment, GSK • Dr Jack Brown, Senior Principal Scientist, Boehringer Ingelheim Register before the 31st January 2019 to save £400 on your booking https://www.smi- Highly Potent Active Pharmaceutical Ingredients 2019 Conference: 13th and 14th May 2019 Post-conference workshop: 15th May 2019 Holiday Inn Kensingston Forum, London, UK End
Account Email Address Account Phone Number Disclaimer Report Abuse
|
|